跳至主要内容
临床试验/JPRN-UMIN000011534
JPRN-UMIN000011534已完成2 期

Phase II study of nab-paclitaxel and carboplatin for elderly patients with non-small cell lung cancer. (KRSG1303) - Phase II study of nab-paclitaxel and carboplatin for elderly patients with non-small cell lung cancer. (KRSG1303)

Kanto respiratory disease study group0 个研究点目标入组 32 人开始时间: 2013年9月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
32

研究概览

简要总结

This trial stopped because the targeted number of cases cannot be achieved.

研究设计

研究类型
Interventional

入排标准

年龄范围
75years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with Symptomatic brain metastasis 2) Patients have only non-measurable lesion 3) Patients with radiotherapy for cancer within 4 weeks 4) Patients with interstitial pneumonia 5) Patients with Serious complications (renal dysfunction, liver dysfunction, cardiac diseases, uncontrolled hypertension or diabetes) 6) Patients with other Serious complications 7) Judged ineligible based on physicians' decision

研究者

发起方
Kanto respiratory disease study group

相似试验